A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease
Clinical trial NCT04173273 · TERMINATED
Trial details
- NCT number
- NCT04173273
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-06
- Primary completion
- 2025-04-23
- Enrollment
- 379
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.